Home Covid Harrison research company Sapience Therapeutics receives second federal grant

Harrison research company Sapience Therapeutics receives second federal grant

Sapience Therapeutics, a Harrison-based company that is involved in developing drugs to treat cancer, has been awarded a second Small Business Innovative Research grant from the federal government’s National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Sapience Therapeutics received $299,860 for fiscal year 2021. It had previously received a grant…

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.